Alzheimer's disease (AD) is a progressive neurodegenerative condition that goes from mild
cognitive impairment in prodromal disease to severely disabling deficits in advanced stages …

Cognitive decline is well recognized during ageing but is often accelerated in women after
menopause. Studies have shown that there are significant gender differences in brain …

Estrogen replacement therapy appears to have significant beneficial effects on cognition
and mood in the elderly. In recent studies, its use has been associated with short term …

The results of recent clinical studies have challenged our previously held view that estrogen
therapy promotes neurological health and prevents or ameliorates Alzheimer's disease. A …

In women the abrupt decline estrogen levels at menopause may be associated with
cognitive deficits and increased risk for Alzheimer's disease (AD); estrogen replacement …

Dementia is characterized by severe memory and other cognitive deficits that interfere with
daily life. Alzheimer disease (AD), the most prevalent type of dementia, is characterized by a …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that accounts for
more than half of all dementia cases in the elderly. Interestingly, the clinical manifestations of …

The ovarian hormone estrogen has long been used to treat the physical symptoms of
menopause and to aid in the prevention of osteoporosis in postmenopausal women …

There is growing evidence that post menopausal use of estrogen may have a beneficial
effect on cognition and may reduce the risk of dementia. In a vast majority of studies, the use …

Within the last few years, there has been a growing interest in the neuroprotective effects of
estrogen and the possible beneficial effects of estrogen in neurodegenerative diseases such …